Document:

ex10_4.htm

Exhibit 10.4

EMPLOYMENT AGREEMENT

AGREEMENT dated  March 1, 2010, between NanoViricides, Inc. ("Employer"), with its principal place of business at 135 Wood Street, Suite 205, West Haven, Connecticut, and Randall Barton (the "Employee"), c/o NanoViricides, Inc., 135 Wood Street, Suite 205, West Haven, Connecticut.

	
1.

	
Employment

The Company agrees to employ the Employee, and the Employee hereby agrees to such employment, subject to the terms and conditions set forth in this Agreement.

	
2.

	
Term

The employment of Employee shall be for a period of four (4) years commencing on the date of this Agreement, renewable annually thereafter upon unanimous approval of the Board of Directors, provided that either party can terminate the employment at any time, for any reason, upon 90 days’ notice (the “Employment Period”).

	
3.

	
Compensation

The Employee’s Compensation and Benefits are set forth in Appendix A.

	
4.

	
Duties.

The Employee’s Duties are set forth in Appendix A.

	
5.

	
Extent of services.

The Employee shall devote his entire time, attention, and energies to the Employer's business and shall not during the term of this Agreement be engaged in any other business activity, whether or not such business activity is pursued for gain, profit, or other pecuniary advantage, except with the consent of employer.  However, the Employee may invest his assets in such form or manner as will not require his serv­ices in the operation of the affairs of the companies in which such investments are made.

	
6.

	
Disclosure of information.

The Employee acknowledges that the Employer's trade secrets, including chemical compounds and other proprietary information, as may exist from time to time are valuable, special, and unique assets of the Employer’s business.  During and after the term of his employ­ment, the Employee agrees not to disclose any information acquired by Employee with respect to any and all confidential and proprietary information of the Employer or the Employer’s business, and to maintain and follow reasonable procedures to prevent unauthorized disclosure of or use of the confidential information and to prevent it from falling in to the public domain or the possession of unauthorized persons.  Employee agrees that for a period of seven (7) years after termination of employment with Employer, he will hold all confidential and/or proprietary information in strict confidence and will not disclose such confidential or proprietary information to any third party, except as expressly agreed to in writing by an officer of Employer.

  

  

  

Notwithstanding the above, confidential or proprietary information will not include information that is:

i)  Lawfully known or available to the Employee from a source other than an employee of Employer or any related or affiliated company;

ii)  Already known to the Employee as shown by written records, before its disclosure;

iii)  Developed independently by the Employee without the use or consideration of or reference to the confidential or proprietary information of the Employer; or

iv)  Within, or later falls within, the public domain, without breach of the Agreement by the Employee.

In the event of a breach or threatened breach by the Employee of the provisions of this paragraph, the Employer shall be entitled to an injunction restraining the Employee from disclosing, in whole or in part, such confidential or proprietary information or from rendering any services to any person, form, corporation, association, or other entity to whom such confidential or proprietary information, in whole or in part, has been disclosed or is threatened to be disclosed.  Nothing herein shall be construed as prohibit­ing the Employer from pursuing any other remedies available to the Employer for such breach or threatened breach, including the recovery of damages from the Employee.  The provisions of this article are supplementary to the provisions of the Restrictive Covenant in Article 9.

	
7.

	
Vacation

The Employee’s Vacation and Holiday policy is set forth in Appendix A.

	
8.

	
Termination

	
A.

	
Termination by Employee

The Employee may terminate this agreement by providing Employer with 30 days written notice of Employee’s intent to terminate his employment and stating the effective date of such termination.

  

  

  

 

	
B.

	
Termination by Employer

Without cause, the Employer may terminate this Agreement at any time without notice to the Employee.

	
C.

	
Surviving Clause

Notwithstanding any termination of this Agreement, whether with cause or without cause, all other provisions of this Agreement remain in full force and effect.

	
9.

	
Restrictive covenant.

A.            If the employment of Employee with Employer shall be terminated for any reason, he shall not provide any Employee shall not provide any services to any competitor, client, or customer of Employer, or any affiliate of Employer then existing, including without limitation TheraCour Pharma, Inc., and AllExcel, Inc., either as an employee, officer, or consult­ant, nor be associated as an employee, officer, partner of any firm engaged in substantially similar research or drug development as Employer, or any affiliate of Employer the existing, for a period of one year from the effective date of such termination.  This restrictive covenant is intended to protect proprietary information and technology disclosed to Employee as a result of Employee’s work, and in consideration of this contract.

B.            For purposes of this Agreement, “proprietary infor­mation” shall mean any information relating to the business of employer, or any entity in which employer has a controlling interest, that has not previously been publicly released by duly authorized representatives of employer and shall include (but shall not be limited to) information encompassed in all research plans, formulas, proposals, business plans, financial infor­mation, costs, pricing information, or investor information and re­cords, and all invention methods, concepts, or ideas used in or reasonably related to the business of Employer or any entity in which Em­ployer or its officers and shareholders have a controlling inter­est.  Employee agrees to regard and preserve as confidential all proprietary information, whether he has such information in his memory or in writing or other physical form.  Employee will not, without written authority from Employer to do so, directly or indirectly, use for his benefit or purposes, nor disclose to others, either during the term of his employment hereunder or thereafter, except as required by the conditions of his employment hereunder, any proprietary information.  Employee agrees not to remove from the premises of Employer or any subsidiary or affiliate of Employer, except as an Employee of Employer in pursuit of the business of Employer or any of its subsidiaries, affiliates or any entity in which Employer has a controlling interest, or except as specifically permitted in writing by Employer any document or object containing or reflecting any proprietary information.  Employee recognizes that all such documents and objects, whether developed by him or by someone else, are the exclusive property of Employer.

C.            All proprietary information and all of Employee’s interest in patents, patent applications, trade secrets, trade­marks, inventions, customer lists, employee lists, procedure, technological innovation, copy­rights, developments, and processes hereafter to the end of the period of the employment hereunder developed by Employee but at Employer's expense are considered automatically assigned to the Employer.  Employee shall execute any and all such assignments and other documents and take any and all such other action as Employer reasonably requests in order to vest in Employ­er all Employee's rights, title and interest in all of the afore­said items, free and clear of any liens or encumbrances.

  

  

  

D.            Employee expressly agrees that the covenants set forth in this section are given to Employer in connection with the employment of Employee by Employer and that such covenants are intended to protect Employer against the competition by Employee, within the terms stated, to the fullest extent deemed reasonable and permitted in law and equity.  In the event that the foregoing limitations upon the conduct of Employee are beyond those permitted by law, such limitation, both as to time and geographical area shall be deemed to be reduced in scope and effect to the maximum extent permitted by law.

	
10.

	
Representations of Employee.

Employee represents and warrants that neither the execution and delivery of this agree­ment nor the performance of his duties hereunder violates the provision of any other agreement to which he is a party or by which he is bound.  Employee further agrees to indemnify employer for all damages in the event that this representation is breached.

	
11.

	
Arbitration.

Any controversy or claim arising out of, or relating to this Agreement, or the breach thereof, shall be set­tled by arbitration in the State of Connecticut in accordance with the rules then obtaining of the American Arbitration Association, and judgment upon the award rendered may be entered and enforced in any court having jurisdiction thereof.  However, such arbitration provision shall not act as a stay of the Employer’s right to seek a restraining order against the Employee’s actual or anticipatory breach of this Agreement of anticipatory disclosure of confidential or proprietary information.

	
12.

	
Notices.

Any notice required or desired to be given under this Agreement shall be deemed given if in writing sent by certified mail to his residence in the case of the Employee, or to its principal office in the case of the Employer.

	
13.

	
Waiver of breach.

The waiver by the Employer of a breach of any provision of this Agreement by the Employee shall not operate or be construed as a waiver of any subsequent breach by the Employee.  No waiver shall be valid unless in writing and signed by an authorized officer of the Employer.

  

  

  

 

	
14.

	
Entire agreement.

This Agreement contains the entire understanding of the parties.  It may not be changed orally but only by an agreement in writing signed by the party against whom enforcement of any waiver, change, modification, extension, or discharge is sought.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date and year first written upon.

	  	
Nanoviricides, Inc.

	  
	  	  	  
	  	  	  
	  	
/s/

	  	  
	  	
By Anil R. Diwan, President

	  
	  	
Duly authorized

	  
	  	  	  
	  	  	  
	  	
/s/

	  	  
	  	
Randall Barton

	  

  

  

  

Appendix A

Duties, Compensation, and Benefits

The Employer reserves the right to change the compensation and benefit policies at all time upon thirty (30) days written notice to the Employee.

	
1.

	
Duties

The Employee shall serve as Chief Scientific Officer, to perform the usual duties of said offices, and shall have responsibility, subject to direction of the Board of Directors, for participating in the management and direction of the Employer's scientific operations, and shall perform such specific other tasks consistent with such position as may from time to time be assigned to him by the Board of Directors.  The Employee shall devote his business time to the performance of his duties hereunder, and shall devote his labor, skill, attention, and best ability in a manner that will faithfully and diligently further the business and interests of the Employer.

	
2.

	
Compensation

	
A.

	
Base Salary

As compensation for the Employee's services hereunder during the Employment Period, the Company shall pay the Employee a base salary of One Hundred Fifty Thousand Dollars ($150,000), payable on a monthly basis.

 

	
B.

	
Common Stock

The Company shall grant 500,000 restricted shares of the Company’s $0.001par value common stock to Employee (the “Common Stock”) upon execution of this Agreement, to vest as follows:

i)  The Employee shall receive 125,000 shares of Common Stock upon execution of this Agreement and an additional 125,000 shares of Common Stock on each anniversary of this Agreement (the “Vesting Date”) until and including March 1, 2013, or until this Agreement is earlier terminated by Employee or Employer.

ii)  In the event that the Employee’s employment is terminated without cause, the Employee shall be entitled to 125,000 shares of Common Stock multiplied by a fraction wherein the numerator is the number of days between the previous Vesting Date and the date of termination and the denominator is 365, said shares of Common Stock to vest as of the date of termination.

iii) The common stock so received and vested hereunder shall not be saleable by employee during the pendency of this agreement.

  

  

  

 

	
3.

	
Benefits

	
A.

	
Health Insurance

 

	
B.

	
Retirement Benefits - Employer contributory SEP IRA

	
4.

	
Holidays and Vacation Days

	
A.

	
Holidays

The Employer observes 13 holidays each year.

	
B.

	
Vacation Days

The Employee may accrue a maximum of ten vacation days.  The Employee will accrue vacation days at the rate of 1 vacation day per 196 hours worked.  Vacation days must be taken consecutively and may only be taken upon thirty days advance written notice to Employer.

	
C.

	
Sick Days

The Employee may accrue a maximum of five sick days.  The Employee will accrue sick days at the rate of 1 sick day for every 392 hours worked. Sick days cannot be banked from one year to the next.Unassociated Document

    
      FIRST
AMENDMENT

      TO

      LOAN
AND SECURITY AGREEMENT

       

      THIS
FIRST AMENDMENT to Loan
and Security Agreement (this “Amendment”) is entered into this 5th day of March,
2010 by and between Silicon Valley Bank (“Bank”) and US DATAWORKS, INC., a
Nevada corporation (“Borrower”) whose address is One Sugar Creek Center Blvd.,
5th Floor, Sugarland, TX 77478.

       

      Recitals

       

      1.           Bank
and Borrower have entered into that certain Loan and Security Agreement dated as
of February 9, 2010  (as the same may from time to time be further
amended, modified, supplemented or restated, the “Loan Agreement”).

       

      2.           Bank
has extended credit to Borrower for the purposes permitted in the Loan
Agreement.

       

      3.           Borrower
has requested that Bank amend the Loan Agreement to revise the provisions
regarding maintenance of bank accounts outside Bank.

       

      4.           Bank
has agreed to so amend certain provisions of the Loan Agreement, but only to the
extent, in accordance with the terms, subject to the conditions and in reliance
upon the representations and warranties set forth below.

       

      Agreement

       

      Now,
Therefore, in
consideration of the foregoing recitals and other good and valuable
consideration, the receipt and adequacy of which is hereby acknowledged, and
intending to be legally bound, the parties hereto agree as follows:

       

      1.           Definitions.  Capitalized
terms used but not defined in this Amendment shall have the meanings given to
them in the Loan Agreement.

       

      2.           Amendment
to Loan Agreement.

       

      2.1           
Section 6.6 (Operating
Accounts).  Section 6.6 is amended in its entirety and replaced
with the following:

       

      “6.6           Operating Accounts. No later
than sixty (60) days after the Effective Date and at all times thereafter,
maintain all of its operating and other deposit accounts and securities accounts
with Bank; provided however that Borrower may maintain account
number _______ at Amegy Bank until the date one hundred twenty (120) days
after the Effective Date so long as such account only has lockbox proceeds and
that any amounts in such account in excess of the amounts needed to cover
outstanding checks/debits shall be immediately transferred to accounts at
Bank.”

       

      
        
          
          

        

        
          1

          
            

          

        

        
          
          

        

      

       

       

      3.           Limitation
of Amendment.

       

      3.1           The
amendment set forth in Section
2, above, is effective for the purposes set forth herein and shall be
limited precisely as written and shall not be deemed to (a) be a consent to any
amendment, waiver or modification of any other term or condition of any Loan
Document, or (b) otherwise prejudice any right or remedy which Bank may now have
or may have in the future under or in connection with any Loan
Document.

       

      3.2           This
Amendment shall be construed in connection with and as part of the Loan
Documents and all terms, conditions, representations, warranties, covenants and
agreements set forth in the Loan Documents, except as herein amended, are hereby
ratified and confirmed and shall remain in full force and effect.

       

      4.           Representations and
Warranties.  To induce Bank to enter into this Amendment,
Borrower hereby represents and warrants to Bank as follows:

       

      4.1           Immediately
after giving effect to this Amendment (a) the representations and warranties
contained in the Loan Documents are true, accurate and complete in all material
respects as of the date hereof (except to the extent such representations and
warranties relate to an earlier date, in which case they are true and correct as
of such date), and (b) no Event of Default has occurred and is
continuing;

       

      4.2           Borrower
has the power and authority to execute and deliver this Amendment and to perform
its obligations under the Loan Agreement, as amended by this
Amendment;

       

      4.3           The
organizational documents of Borrower delivered to Bank on the Effective Date
remain true, accurate and complete and have not been amended, supplemented or
restated and are and continue to be in full force and effect;

       

      4.4           The
execution and delivery by Borrower of this Amendment and the performance by
Borrower of its obligations under the Loan Agreement, as amended by this
Amendment, have been duly authorized;

       

      4.5           The
execution and delivery by Borrower of this Amendment and the performance by
Borrower of its obligations under the Loan Agreement, as amended by this
Amendment, do not and will not contravene (a) any law or regulation binding on
or affecting Borrower, (b) any contractual restriction with a Person binding on
Borrower, (c) any order, judgment or decree of any court or other governmental
or public body or authority, or subdivision thereof, binding on Borrower, or (d)
the organizational documents of Borrower;

       

      4.6           The
execution and delivery by Borrower of this Amendment and the performance by
Borrower of its obligations under the Loan Agreement, as amended by this
Amendment, do not require any order, consent, approval, license, authorization
or validation of, or filing, recording or registration with, or exemption by any
governmental or public body or authority, or subdivision thereof, binding on
either Borrower, except as already has been obtained or made; and

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

       

      4.7           This
Amendment has been duly executed and delivered by Borrower and is the binding
obligation of Borrower, enforceable against Borrower in accordance with its
terms, except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, liquidation, moratorium or other similar laws of general
application and equitable principles relating to or affecting creditors’
rights.

       

      5.           Counterparts.  This
Amendment may be executed in any number of counterparts and all of such
counterparts taken together shall be deemed to constitute one and the same
instrument.

       

      6.           Effectiveness.  This
Amendment shall be deemed effective upon the due execution and delivery to Bank
of this Amendment by each party hereto.

       

      [Signature
page follows.]

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

       

       

       

       

      In
Witness Whereof, the parties hereto have caused this Amendment to be duly
executed and delivered as of the date first written above.

       

      
        	
                BANK

                 

                SILICON
      VALLEY BANK

                 

                 

                By:
      /s/ Phillip A.
      Wright

                Name: Phillip A.
      Wright

                Title:
      Relationship
      Manager

              	
                BORROWER

                 

                US
      DATAWORKS, INC.

                 

                 

                By:
      /s/ Randall J.
      Frapart

                Name: Randall J.
      Frapart

                Title:
      Chief Financial
      Officer

              
	 
      	 
      

      

      
 

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

      
        
          
          

        

        
          4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]